Abstract
Current Alzheimer Research
Title: Treatment of Alzheimers Disease: The Beginning of a New Era Dale Schenk, ISOA - October 5th-6th, 2005
Volume: 3 Issue: 3
Author(s): Dale Schenk
Affiliation:
Keywords: neuronal degeneration, CSF, Abeta immunotherapy, beta amyloid peptide, tau kinases
Abstract:
Export Options
About this article
Cite this article as:
Schenk Dale, Treatment of Alzheimers Disease: The Beginning of a New Era Dale Schenk, ISOA - October 5th-6th, 2005, Current Alzheimer Research 2006; 3 (3) . https://dx.doi.org/10.2174/156720506777632907
DOI https://dx.doi.org/10.2174/156720506777632907 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Efficacy and Mechanisms of Action of Lithium Augmentation in Refractory Major Depression
Current Pharmaceutical Design Basic Symptoms and the Prediction of First-Episode Psychosis
Current Pharmaceutical Design Purines as Neurotransmitters and Neuromodulators in Blood Vessels
Current Vascular Pharmacology Safflor Protected Rat Cerebral Ischemia-Reperfusion Injury Through Inhibiting the Expression of NF-kB and IL-1β
Neuroscience and Biomedical Engineering (Discontinued) Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Lysophospholipid Receptors as Potential Drug Targets in Tissue Transplantation and Autoimmune Diseases
Current Pharmaceutical Design Editorial: Multitarget Molecules for Alzheimer's Disease Therapy
Current Topics in Medicinal Chemistry Recombinant Interleukin-12 for Immunotherapy: A Double-Sided Sword
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review
Central Nervous System Agents in Medicinal Chemistry Blood microRNA-15a Correlates with IL-6, IGF-1 and Acute Cerebral Ischemia
Current Neurovascular Research Maternal Nutrient Restriction is not Equivalent to Maternal Biological Stress
Current Drug Targets Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study
Current Topics in Medicinal Chemistry Peptides as Modulators of α-Synuclein Aggregation
Protein & Peptide Letters Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides
Current Pharmaceutical Biotechnology Stem Cell-Based Approaches for Intervertebral Disc Regeneration
Current Stem Cell Research & Therapy WISP1: Clinical Insights for a Proliferative and Restorative Member of the CCN Family
Current Neurovascular Research Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling
Current Medicinal Chemistry Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis
Current Medicinal Chemistry